文献速递神经创伤脑血管病外科

首次颅骨修补术后手术部位感染的危险因素及万古霉素粉末预防效果评估

Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty.
PubMed 文献 · J Neurosurg · 2017-05-12

该回顾性队列研究纳入2008年1月1日至2014年7月31日期间在一家学术健康中心因非感染指征行首次颅骨修补术的258例成人患者,15例(5.8%)发生手术部位感染(SSI)。切口内万古霉素粉末(VP)组92例(35.7%)与无VP组166例(64.3%)的SSI率分别为6.5%和5.4%(p=0.72),VP与SSI风险降低或并发症增加均无关。多因素分析显示既往同侧开颅术(OR 3.37,95%CI 1.06-10.79)和假体植入物(OR 3.93,95%CI 1.15-13.40)是SSI的显著危险因素。

要点

  • VP组与无VP组的SSI率分别为6.5%和5.4%(p=0.72),无显著差异。
  • 切口内VP与SSI风险降低无关,也与并发症风险增加无关。
  • 既往同侧开颅术和假体植入物是首次颅骨修补术后SSI的显著危险因素。

核心结论

  • 在本研究中,切口内万古霉素粉末与手术部位感染风险降低无关,也与并发症风险增加无关。
  • 既往同侧开颅术和假体植入物是首次颅骨修补术后手术部位感染的危險因素。

研究设计与样本

  • 回顾性队列研究,纳入2008年1月1日至2014年7月31日在一家学术健康中心因非感染指征行首次颅骨修补术的成人患者。
  • 共258例患者,其中VP组92例(35.7%),无VP组166例(64.3%)。

主要发现

  • 258例中15例(5.8%)发生SSI;VP组SSI率6.5%,无VP组5.4%(p=0.72)。
  • 双变量分析中SSI危险因素包括糖尿病(OR 3.65,95%CI 1.07-12.44)、颅骨修补术前多次开颅手术(OR 4.39,95%CI 1.47-13.18)、既往同侧开颅术(OR 4.73,95%CI 1.57-14.24)和假体植入物(OR 4.51,95%CI 1.40-14.59)。
  • 多变量分析确认既往同侧开颅术(OR 3.37,95%CI 1.06-10.79)和假体植入物(OR 3.93,95%CI 1.15-13.40)为SSI的显著危险因素。
  • 调整潜在混杂因素后,发生SSI的患者较未发生SSI者更可能再入院(OR 7.28,95%CI 2.07-25.60)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Craniectomy is often performed to decrease intracranial pressure following trauma and vascular injuries. The subsequent cranioplasty procedures may be complicated by surgical site infections (SSIs) due to prior trauma, foreign implants, and multiple surgeries through a common incision. Several studies have found that intrawound vancomycin powder (VP) is associated with decreased risk of SSIs after spine operations. However, no previously published study has evaluated the effectiveness of VP in cranioplasty procedures. The purpose of this study was to determine whether intrawound VP is associated with decreased risk of SSIs, to evaluate VP's safety, and to identify risk factors for SSIs after cranioplasty among patients undergoing first-time cranioplasty. METHODS The authors conducted a retrospective cohort study of adult patients undergoing first-time cranioplasty for indications other than infections from January 1, 2008, to July 31, 2014, at an academic health center. Data on demographics, possible risk factors for SSIs, and treatment with VP were collected from the patients' electronic health records. RESULTS During the study period, 258 patients underwent first-time cranioplasties, and 15 (5.8%) of these patients acquired SSIs. Ninety-two patients (35.7%) received intrawound VP (VP group) and 166 (64.3%) did not (no-VP group). Patients in the VP group and the no-VP group were similar with respect to age, sex, smoking history, body mass index, and SSI rates (VP group 6.5%, no-VP group 5.4%, p = 0.72). Patients in the VP group were less likely than those in the no-VP group to have undergone craniectomy for tumors and were more likely to have an American Society of Anesthesiologists physical status score > 2. Intrawound VP was not associated with other postoperative complications. Risk factors for SSI from the bivariable analyses were diabetes (odds ratio [OR] 3.65, 95% CI 1.07-12.44), multiple craniotomy procedures before the cranioplasty (OR 4.39, 95% CI 1.47-13.18), prior same-side craniotomy (OR 4.73, 95% CI 1.57-14.24), and prosthetic implants (OR 4.51, 95% CI 1.40-14.59). The multivariable analysis identified prior same-side craniotomy (OR 3.37, 95% CI 1.06-10.79) and prosthetic implants (OR 3.93, 95% CI 1.15-13.40) as significant risk factors for SSIs. After adjusting for potential confounders, patients with SSIs were more likely than those without SSIs to be readmitted (OR 7.28, 95% CI 2.07-25.60). CONCLUSIONS In this study, intrawound VP was not associated with a decreased risk of SSIs or with an increased risk of complications. Prior same-side craniotomy and prosthetic implants were risk factors for SSI after first-time cranioplasty.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Abode-Iyamah KO, Chiang HY, Winslow N, et al. Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty. J Neurosurg. 2017. PMID: 28498056. doi:10.3171/2016.12.JNS161967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。